---
title: DIASENTINEL: An Auditable Multi-Agent System for Guideline-Grounded Diabetes Risk Screening
url: http://arxiv.org/abs/2608.31128v1
type: paper-summary
date: 2026-08-31
source_paper: 2026-08-31_17-40-43Z_DIASENTINEL_AnAuditableMulti_AgentSystemforGuideli.md
generated_at: 2026-08-31 22:11
model: nvidia/nemotron-3-nano-4b
---

## Summary
DIASENTINEL is a fully on‑premise multi‑agent system that screens for one‑year type 2 diabetes risk using electronic health records and generates guideline‑grounded reports. The authors demonstrate real‑time batch screening and an interactive patient interface with verified citations, showing the framework can produce reliable clinical decision support without hallucinations.

## Key Takeaways
- The system combines calibrated risk prediction with deterministic signal extraction to produce consistent risk scores from EHR data.
- It fuses reciprocal rank over ADA guidelines using a hybrid verification layer that includes rule‑based checks and LLM entailment, ensuring each recommendation is auditable.
- All components run on‑premise, preserving privacy while providing real‑time batch screening dashboards and patient reports with cited evidence.

## Context
Current AI clinical tools often rely on cloud models that expose data to external servers, raising concerns about HIPAA compliance. This work addresses those issues by moving the entire pipeline locally, enabling transparent audit trails and eliminating reliance on proprietary APIs.

## Implications
Healthcare providers can adopt DIASENTINEL to improve early detection of diabetes while maintaining regulatory compliance. The framework sets a benchmark for auditable AI decision support that balances safety with usability in real‑world settings.

## Original Paper Reference
- **Source**: [Original Paper](http://arxiv.org/abs/2608.31128v1)
